On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

The Guardian has announced it will stop posting on X, formerly Twitter, becoming the latest in a growing list of companies ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. The company’s diabetes segment lags behind competitors like DexCom and Abbott due to ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

and also in comparison to Medtronic's Guardian. Now we could argue that Dexcom might be able to grow at a higher pace but that top-line growth has to come from taking market share. And in my ...

With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelect™ Pulsed Field Ablation System, which was FDA approved ...

The guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient ...

The Affera mapping and ablation system with the Sphere-9 catheter [Images courtesy of Medtronic] Medtronic (NYSE:MDT) today said it received FDA approval for its Affera mapping and ablation system ...

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G, 770G ...

The owner of the Guardian has confirmed it is in talks to sell the Observer, the world's oldest Sunday newspaper, to Tortoise Media. Tortoise has approached Guardian Media Group (GMG) with an ...

the MiniMed 780G system with Guardian 4 sensor will automatically adjust and correct insulin delivery every 5 minutes with no fingersticks. By pairing the MiniMed 780G system with the recently ...